Using human pluripotent stem cell models to study autism in the era of big data.
Ralda Nehme, Lindy E Barrett
PMID 32293529WHAT IT FOUND
Stem cell models for autism are currently biased toward male cells of European ancestry and often lack statistical power.
Researchers argue that without diverse cell lines and better reporting standards, discoveries will fail to reflect the global autism population.
Key findings
01Most autism stem cell studies use male cells, with 97.8% of patient lines being XY, despite females being diagnosed with autism.
02Genetic datasets and stem cell collections are heavily skewed toward European ancestry, reducing the accuracy of predictions for other populations.
03Published studies on idiopathic autism often use very small sample sizes, with nearly all using fewer than ten cell lines.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a review, not a study of patients or treatments. It describes the state of laboratory science, not clinical outcomes. It relies on the authors' interpretation of existing literature and their own advocacy for specific methodological changes. The findings apply to basic science researchers, not to clinical practice or patient care.
Declared interests
The authors declare no competing interests. The work was supported by grants from the Simons Foundation Autism Research Initiative and the National Institutes of Health.
The easy way to misread this
Do not interpret this paper as evidence that stem cell treatments for autism are available or effective. It is a critique of how scientists study autism in the lab, not a report on patient outcomes or therapies.